Speaker(s): 

Nori Zaccheo PharmD. Candidate, Geisinger Student - has nothing to disclose.

Moderator(s): 

Christopher DeFrancesco, PharmD, Clinical Pharmacist / Asst Pharmacy Residency Program Director Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Apply weight-based principles to appropriately dose and administer epinephrine for anaphylaxis.​

2. Identify the rationale for continuing basal insulin in NPO patients with type 1 diabetes.​

3. Determine when and which statin therapy is indicated in patients with type 2 diabetes, regardless of baseline LDL-C.​

4. Recognize the relationship between hypomagnesemia and refractory hypokalemia and the importance of magnesium replacement.​

5. Differentiate the role of calcitonin from definitive therapy in the management of severe hypercalcemia.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH; Anil Singh MD; Roop Parlapalli, MD, FHM, FACP; Carolyn Chilewshi, PA-C; Emilie Detweiler, PharmD, RPh; Alexa Kerecman, CRNP; John Sacino, CPhT, and Miranda Steigler, PharmD, RPh have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.